Category: Patents
-
Federal Circuit decision in Optis v. Apple SEP case shows why UK courts should leave other jurisdictions alone: misconception exposed
In the seemingly neverending SEP story between Optis and Apple, the Federal Circuit has ordered a U.S. retrial on the merits and what would be a third damages trial in the same case.
-
Novartis and MSN settle part of chronic heart failure patent fight, but key patent remains
Novartis and MSN have settled one prong of their U.S. Entresto patent infringement dispute in the Federal Circuit, but the companies will continue to litigate over a second patent as Novartis strives to defend its corner of the chronic heart failure drug market.
-
Novo Nordisk lets key Ozempic patent lapse in Canada, despite being world’s second-largest semaglutide market
Novo Nordisk has continued to pay for a key Ozempic patent in several jurisdictions across the world, and even obtained an adjusted expiration date in the U.S., but the company stopped paying fees in Canada as far back as 2018, records show.
-
UPC Dusseldorf LD affirms 10x v. Curio preliminary injunction in final ruling, creates opening for late claim construction arguments
Having recently settled its dispute with Bruker (NanoString) on presumably favorable terms, 10x is now continuing its patent enforcement with a victory over Curio.
-
Microsoft seeks declaratory judgment against Biogy over RFC one-time passcode patent in Northern District of California
Microsoft has alleged that Biogy’s prior “litigation behavior” confirms it will be its next target in an RFC patent infringement suit.
-
BREAKING: Datang sues fellow Chinese company Xiaomi in Munich over three 4G/5G standard-essential patents
This is just a short news piece. A spokeswoman for the Landgericht München I (Munich I Regional Court) confirmed the pendency of three recently-filed Datang v. Xiaomi cases: All three are essential to the LTE (Long Term Evolution) standard, which is known as 4G but also forms the basis of 5G. Datang is a subsidiary…
-
In U.S. court filing in ZTE case, Samsung raises “bias concerns” over Chinese FRAND proceedings: SEP-related sinophobia
Samsung just told a U.S. court it does not expect fairness from the Chinese courts because of the Chinese govenrment’s ownership position in ZTE.
-
Nokia expands wireless patent licensing in automotive sector to WiFi, expects more Chinese auto deals or litigation this year
“This year will be a turning point for automotive licensing in China… either more Chinese automotive companies will sign licences or there will be more litigation by patent holders,” Nokia’s Chief Licensing Officer for Wireless Technologies, Susanna Martikainen writes in a blog post.
-
Federal Circuit upholds Moderna’s win in COVID vaccine dispute against Alnylam
Alnylam acted as its own lexicographer in defining keywords in patent specifications, foreclosing its own infringement allegations against Moderna, the United States Court of Appeals for the Federal Circuit has ruled.
-
Conditioning interim license on jurisdiction of preference is not acting in “bad faith”: ZTE and Samsung face off in UK hearing
Samsung’s opening arguments suggest Chinese courts will produce a biased judgment, counsel for ZTE has argued.